{
  "docId": "019dd923-5efe-75c0-8dfe-f659060b287f",
  "docSlug": "bc4fb8cae61b29e3",
  "documentTitle": "2024 Investor Day",
  "authorId": "Revvity",
  "authorName": "Revvity",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 74,
  "pageCount": 109,
  "prevPage": 73,
  "nextPage": 75,
  "slideType": "market_landscape",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The chart shows the growth of conditions approved for newborn screening (NBS) from 54 in 2007 to 64 in 2024.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "callout_box",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5efe-75c0-8dfe-f659060b287f/74",
  "deckHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f",
  "deckJsonHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f.json",
  "deckAnchorHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f#slide-74",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.6,
        "y": 0.3
      },
      "kind": "callout",
      "text": "Opportunities",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7314d1de-75cd-4f79-8be0-961e82c01670",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Expand menu for treatable rare diseases and evolve with cutting-edge science",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-7dab-745b-a23e-e9a79e9d15de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.03,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Total # of conditions approved for NBS",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f01ec3ee-878c-4dac-8001-43126e9ac56e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.32,
        "x": 0.62,
        "y": 0.4
      },
      "kind": "list",
      "text": "Expand menu for treatable rare diseases and evolve with cutting-edge science; Pipeline specific assays based on Pharma's attention to novel treatments for rare diseases; Potential to leverage newborn screening expertise into CDx strategies with key customers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4efa5b6-012e-4121-82b2-fd7e4e9a0712",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Total # of conditions: 64",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-7dab-745b-a23e-eebea2d5c842",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "RUSP Overview: Standardized list of disorders guiding U.S. state-led universal NBS programs",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74bb9a77-b99c-45d0-9787-cbacad226c86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Expanding Recommended Uniform Screening Panel (RUSP) menu and adoption through innovation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c57ba7a-3c20-4221-8ad5-1e49dc9e977d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 90,
      "from": 24,
      "beatId": "019debe1-68e8-744d-bb8c-31575e75a2a5",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": null,
      "evidence": "Segment deep dives: LS Solutions, Signals, Diagnostics, Repro Health, innovation",
      "position": 4,
      "confidence": 78,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 105,
      "from": 24,
      "beatId": "019debe1-69ae-7785-8a5f-959d8f6cab55",
      "arcName": "The Transformation Tale",
      "arcSlug": "transformation-tale",
      "beatName": "The Bridge",
      "beatSlug": null,
      "evidence": "Segment growth drivers and operating model that bridge to LRP targets",
      "position": 3,
      "confidence": 65,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 78,
      "from": 69,
      "name": "Build Up",
      "slug": "33-build-up",
      "bestFor": "Pricing justification, cost estimation, market sizing",
      "matchId": "019debe1-6b6c-7286-afba-9f60da9df917",
      "evidence": "p71 three drivers; p72-75 evidence per driver; p76 waterfall buildup; p78 weighted to 6-8%",
      "position": 11,
      "objective": "Build Reproductive Health 2-4% growth and roll up Diagnostics",
      "structure": "The Base -> Add Component A -> Add Component B -> Add Component C -> The Total",
      "confidence": 82,
      "description": "Start from zero and add components to arrive at a total"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}